Global IBS-C Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global IBS-C Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The Global Info Research report includes an overview of the development of the IBS-C Drugs industry chain, the market status of Hospital Pharmacies (Linaclotide, Lubiprostone), Retail Pharmacies (Linaclotide, Lubiprostone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IBS-C Drugs.
Regionally, the report analyzes the IBS-C Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IBS-C Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IBS-C Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IBS-C Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Linaclotide, Lubiprostone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IBS-C Drugs market.
Regional Analysis: The report involves examining the IBS-C Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IBS-C Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IBS-C Drugs:
Company Analysis: Report covers individual IBS-C Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IBS-C Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to IBS-C Drugs. It assesses the current state, advancements, and potential future developments in IBS-C Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IBS-C Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IBS-C Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe IBS-C Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IBS-C Drugs, with price, sales, revenue and global market share of IBS-C Drugs from 2019 to 2024.
Chapter 3, the IBS-C Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and IBS-C Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IBS-C Drugs.
Chapter 14 and 15, to describe IBS-C Drugs sales channel, distributors, customers, research findings and conclusion.
The Global Info Research report includes an overview of the development of the IBS-C Drugs industry chain, the market status of Hospital Pharmacies (Linaclotide, Lubiprostone), Retail Pharmacies (Linaclotide, Lubiprostone), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of IBS-C Drugs.
Regionally, the report analyzes the IBS-C Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global IBS-C Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the IBS-C Drugs market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the IBS-C Drugs industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Pcs), revenue generated, and market share of different by Type (e.g., Linaclotide, Lubiprostone).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the IBS-C Drugs market.
Regional Analysis: The report involves examining the IBS-C Drugs market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the IBS-C Drugs market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to IBS-C Drugs:
Company Analysis: Report covers individual IBS-C Drugs manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards IBS-C Drugs This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital Pharmacies, Retail Pharmacies).
Technology Analysis: Report covers specific technologies relevant to IBS-C Drugs. It assesses the current state, advancements, and potential future developments in IBS-C Drugs areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the IBS-C Drugs market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
IBS-C Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Linaclotide
- Lubiprostone
- Osmotic Laxatives
- Stimulant Laxatives
- Others
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Catalent Pharmaceuticals Solutions
- Nestle
- Abbott Laboratories
- Synergy Pharmaceuticals
- Sucampo Pharmaceuticals
- Novartis Pharma Ag
- Astellas Pharmaceuticals
- Ardelyx, Inc
- Synthetic Biologics, Inc
- Teva Pharmaceutical Industries
- Bama-Geve, SLU
- Ferring BV
- Ironwood Pharmaceuticals, Inc
- Salix Pharmaceuticals Ltd
- Norgine B.V
- Prometheus Laboratories Inc
- Actavis Nordic A/S
- Albireo Pharma Inc
- Yuhan Corp
- Astrazeneca Plc
- The Menarini Group
- Ono Pharmaceutical Co., Ltd
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe IBS-C Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of IBS-C Drugs, with price, sales, revenue and global market share of IBS-C Drugs from 2019 to 2024.
Chapter 3, the IBS-C Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the IBS-C Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and IBS-C Drugs market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of IBS-C Drugs.
Chapter 14 and 15, to describe IBS-C Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of IBS-C Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IBS-C Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Linaclotide
1.3.3 Lubiprostone
1.3.4 Osmotic Laxatives
1.3.5 Stimulant Laxatives
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global IBS-C Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global IBS-C Drugs Market Size & Forecast
1.5.1 Global IBS-C Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global IBS-C Drugs Sales Quantity (2019-2030)
1.5.3 Global IBS-C Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Catalent Pharmaceuticals Solutions
2.1.1 Catalent Pharmaceuticals Solutions Details
2.1.2 Catalent Pharmaceuticals Solutions Major Business
2.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Services
2.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Catalent Pharmaceuticals Solutions Recent Developments/Updates
2.2 Nestle
2.2.1 Nestle Details
2.2.2 Nestle Major Business
2.2.3 Nestle IBS-C Drugs Product and Services
2.2.4 Nestle IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Nestle Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories IBS-C Drugs Product and Services
2.3.4 Abbott Laboratories IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 Synergy Pharmaceuticals
2.4.1 Synergy Pharmaceuticals Details
2.4.2 Synergy Pharmaceuticals Major Business
2.4.3 Synergy Pharmaceuticals IBS-C Drugs Product and Services
2.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Synergy Pharmaceuticals Recent Developments/Updates
2.5 Sucampo Pharmaceuticals
2.5.1 Sucampo Pharmaceuticals Details
2.5.2 Sucampo Pharmaceuticals Major Business
2.5.3 Sucampo Pharmaceuticals IBS-C Drugs Product and Services
2.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sucampo Pharmaceuticals Recent Developments/Updates
2.6 Novartis Pharma Ag
2.6.1 Novartis Pharma Ag Details
2.6.2 Novartis Pharma Ag Major Business
2.6.3 Novartis Pharma Ag IBS-C Drugs Product and Services
2.6.4 Novartis Pharma Ag IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Pharma Ag Recent Developments/Updates
2.7 Astellas Pharmaceuticals
2.7.1 Astellas Pharmaceuticals Details
2.7.2 Astellas Pharmaceuticals Major Business
2.7.3 Astellas Pharmaceuticals IBS-C Drugs Product and Services
2.7.4 Astellas Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Astellas Pharmaceuticals Recent Developments/Updates
2.8 Ardelyx, Inc
2.8.1 Ardelyx, Inc Details
2.8.2 Ardelyx, Inc Major Business
2.8.3 Ardelyx, Inc IBS-C Drugs Product and Services
2.8.4 Ardelyx, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ardelyx, Inc Recent Developments/Updates
2.9 Synthetic Biologics, Inc
2.9.1 Synthetic Biologics, Inc Details
2.9.2 Synthetic Biologics, Inc Major Business
2.9.3 Synthetic Biologics, Inc IBS-C Drugs Product and Services
2.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Synthetic Biologics, Inc Recent Developments/Updates
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries IBS-C Drugs Product and Services
2.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.11 Bama-Geve, SLU
2.11.1 Bama-Geve, SLU Details
2.11.2 Bama-Geve, SLU Major Business
2.11.3 Bama-Geve, SLU IBS-C Drugs Product and Services
2.11.4 Bama-Geve, SLU IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bama-Geve, SLU Recent Developments/Updates
2.12 Ferring BV
2.12.1 Ferring BV Details
2.12.2 Ferring BV Major Business
2.12.3 Ferring BV IBS-C Drugs Product and Services
2.12.4 Ferring BV IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Ferring BV Recent Developments/Updates
2.13 Ironwood Pharmaceuticals, Inc
2.13.1 Ironwood Pharmaceuticals, Inc Details
2.13.2 Ironwood Pharmaceuticals, Inc Major Business
2.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product and Services
2.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ironwood Pharmaceuticals, Inc Recent Developments/Updates
2.14 Salix Pharmaceuticals Ltd
2.14.1 Salix Pharmaceuticals Ltd Details
2.14.2 Salix Pharmaceuticals Ltd Major Business
2.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Product and Services
2.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Salix Pharmaceuticals Ltd Recent Developments/Updates
2.15 Norgine B.V
2.15.1 Norgine B.V Details
2.15.2 Norgine B.V Major Business
2.15.3 Norgine B.V IBS-C Drugs Product and Services
2.15.4 Norgine B.V IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Norgine B.V Recent Developments/Updates
2.16 Prometheus Laboratories Inc
2.16.1 Prometheus Laboratories Inc Details
2.16.2 Prometheus Laboratories Inc Major Business
2.16.3 Prometheus Laboratories Inc IBS-C Drugs Product and Services
2.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Prometheus Laboratories Inc Recent Developments/Updates
2.17 Actavis Nordic A/S
2.17.1 Actavis Nordic A/S Details
2.17.2 Actavis Nordic A/S Major Business
2.17.3 Actavis Nordic A/S IBS-C Drugs Product and Services
2.17.4 Actavis Nordic A/S IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Actavis Nordic A/S Recent Developments/Updates
2.18 Albireo Pharma Inc
2.18.1 Albireo Pharma Inc Details
2.18.2 Albireo Pharma Inc Major Business
2.18.3 Albireo Pharma Inc IBS-C Drugs Product and Services
2.18.4 Albireo Pharma Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Albireo Pharma Inc Recent Developments/Updates
2.19 Yuhan Corp
2.19.1 Yuhan Corp Details
2.19.2 Yuhan Corp Major Business
2.19.3 Yuhan Corp IBS-C Drugs Product and Services
2.19.4 Yuhan Corp IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Yuhan Corp Recent Developments/Updates
2.20 Astrazeneca Plc
2.20.1 Astrazeneca Plc Details
2.20.2 Astrazeneca Plc Major Business
2.20.3 Astrazeneca Plc IBS-C Drugs Product and Services
2.20.4 Astrazeneca Plc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Astrazeneca Plc Recent Developments/Updates
2.21 The Menarini Group
2.21.1 The Menarini Group Details
2.21.2 The Menarini Group Major Business
2.21.3 The Menarini Group IBS-C Drugs Product and Services
2.21.4 The Menarini Group IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 The Menarini Group Recent Developments/Updates
2.22 Ono Pharmaceutical Co., Ltd
2.22.1 Ono Pharmaceutical Co., Ltd Details
2.22.2 Ono Pharmaceutical Co., Ltd Major Business
2.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product and Services
2.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IBS-C DRUGS BY MANUFACTURER
3.1 Global IBS-C Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global IBS-C Drugs Revenue by Manufacturer (2019-2024)
3.3 Global IBS-C Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of IBS-C Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 IBS-C Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 IBS-C Drugs Manufacturer Market Share in 2023
3.5 IBS-C Drugs Market: Overall Company Footprint Analysis
3.5.1 IBS-C Drugs Market: Region Footprint
3.5.2 IBS-C Drugs Market: Company Product Type Footprint
3.5.3 IBS-C Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IBS-C Drugs Market Size by Region
4.1.1 Global IBS-C Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global IBS-C Drugs Consumption Value by Region (2019-2030)
4.1.3 Global IBS-C Drugs Average Price by Region (2019-2030)
4.2 North America IBS-C Drugs Consumption Value (2019-2030)
4.3 Europe IBS-C Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific IBS-C Drugs Consumption Value (2019-2030)
4.5 South America IBS-C Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa IBS-C Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global IBS-C Drugs Sales Quantity by Type (2019-2030)
5.2 Global IBS-C Drugs Consumption Value by Type (2019-2030)
5.3 Global IBS-C Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IBS-C Drugs Sales Quantity by Application (2019-2030)
6.2 Global IBS-C Drugs Consumption Value by Application (2019-2030)
6.3 Global IBS-C Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America IBS-C Drugs Sales Quantity by Type (2019-2030)
7.2 North America IBS-C Drugs Sales Quantity by Application (2019-2030)
7.3 North America IBS-C Drugs Market Size by Country
7.3.1 North America IBS-C Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America IBS-C Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe IBS-C Drugs Sales Quantity by Type (2019-2030)
8.2 Europe IBS-C Drugs Sales Quantity by Application (2019-2030)
8.3 Europe IBS-C Drugs Market Size by Country
8.3.1 Europe IBS-C Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe IBS-C Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific IBS-C Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific IBS-C Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific IBS-C Drugs Market Size by Region
9.3.1 Asia-Pacific IBS-C Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific IBS-C Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America IBS-C Drugs Sales Quantity by Type (2019-2030)
10.2 South America IBS-C Drugs Sales Quantity by Application (2019-2030)
10.3 South America IBS-C Drugs Market Size by Country
10.3.1 South America IBS-C Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America IBS-C Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IBS-C Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa IBS-C Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa IBS-C Drugs Market Size by Country
11.3.1 Middle East & Africa IBS-C Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa IBS-C Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 IBS-C Drugs Market Drivers
12.2 IBS-C Drugs Market Restraints
12.3 IBS-C Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IBS-C Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of IBS-C Drugs
13.3 IBS-C Drugs Production Process
13.4 IBS-C Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IBS-C Drugs Typical Distributors
14.3 IBS-C Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of IBS-C Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global IBS-C Drugs Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Linaclotide
1.3.3 Lubiprostone
1.3.4 Osmotic Laxatives
1.3.5 Stimulant Laxatives
1.3.6 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global IBS-C Drugs Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Online Pharmacies
1.5 Global IBS-C Drugs Market Size & Forecast
1.5.1 Global IBS-C Drugs Consumption Value (2019 & 2023 & 2030)
1.5.2 Global IBS-C Drugs Sales Quantity (2019-2030)
1.5.3 Global IBS-C Drugs Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Catalent Pharmaceuticals Solutions
2.1.1 Catalent Pharmaceuticals Solutions Details
2.1.2 Catalent Pharmaceuticals Solutions Major Business
2.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Services
2.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Catalent Pharmaceuticals Solutions Recent Developments/Updates
2.2 Nestle
2.2.1 Nestle Details
2.2.2 Nestle Major Business
2.2.3 Nestle IBS-C Drugs Product and Services
2.2.4 Nestle IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Nestle Recent Developments/Updates
2.3 Abbott Laboratories
2.3.1 Abbott Laboratories Details
2.3.2 Abbott Laboratories Major Business
2.3.3 Abbott Laboratories IBS-C Drugs Product and Services
2.3.4 Abbott Laboratories IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Abbott Laboratories Recent Developments/Updates
2.4 Synergy Pharmaceuticals
2.4.1 Synergy Pharmaceuticals Details
2.4.2 Synergy Pharmaceuticals Major Business
2.4.3 Synergy Pharmaceuticals IBS-C Drugs Product and Services
2.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Synergy Pharmaceuticals Recent Developments/Updates
2.5 Sucampo Pharmaceuticals
2.5.1 Sucampo Pharmaceuticals Details
2.5.2 Sucampo Pharmaceuticals Major Business
2.5.3 Sucampo Pharmaceuticals IBS-C Drugs Product and Services
2.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sucampo Pharmaceuticals Recent Developments/Updates
2.6 Novartis Pharma Ag
2.6.1 Novartis Pharma Ag Details
2.6.2 Novartis Pharma Ag Major Business
2.6.3 Novartis Pharma Ag IBS-C Drugs Product and Services
2.6.4 Novartis Pharma Ag IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Novartis Pharma Ag Recent Developments/Updates
2.7 Astellas Pharmaceuticals
2.7.1 Astellas Pharmaceuticals Details
2.7.2 Astellas Pharmaceuticals Major Business
2.7.3 Astellas Pharmaceuticals IBS-C Drugs Product and Services
2.7.4 Astellas Pharmaceuticals IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Astellas Pharmaceuticals Recent Developments/Updates
2.8 Ardelyx, Inc
2.8.1 Ardelyx, Inc Details
2.8.2 Ardelyx, Inc Major Business
2.8.3 Ardelyx, Inc IBS-C Drugs Product and Services
2.8.4 Ardelyx, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Ardelyx, Inc Recent Developments/Updates
2.9 Synthetic Biologics, Inc
2.9.1 Synthetic Biologics, Inc Details
2.9.2 Synthetic Biologics, Inc Major Business
2.9.3 Synthetic Biologics, Inc IBS-C Drugs Product and Services
2.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Synthetic Biologics, Inc Recent Developments/Updates
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business
2.10.3 Teva Pharmaceutical Industries IBS-C Drugs Product and Services
2.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Teva Pharmaceutical Industries Recent Developments/Updates
2.11 Bama-Geve, SLU
2.11.1 Bama-Geve, SLU Details
2.11.2 Bama-Geve, SLU Major Business
2.11.3 Bama-Geve, SLU IBS-C Drugs Product and Services
2.11.4 Bama-Geve, SLU IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Bama-Geve, SLU Recent Developments/Updates
2.12 Ferring BV
2.12.1 Ferring BV Details
2.12.2 Ferring BV Major Business
2.12.3 Ferring BV IBS-C Drugs Product and Services
2.12.4 Ferring BV IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Ferring BV Recent Developments/Updates
2.13 Ironwood Pharmaceuticals, Inc
2.13.1 Ironwood Pharmaceuticals, Inc Details
2.13.2 Ironwood Pharmaceuticals, Inc Major Business
2.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Product and Services
2.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Ironwood Pharmaceuticals, Inc Recent Developments/Updates
2.14 Salix Pharmaceuticals Ltd
2.14.1 Salix Pharmaceuticals Ltd Details
2.14.2 Salix Pharmaceuticals Ltd Major Business
2.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Product and Services
2.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Salix Pharmaceuticals Ltd Recent Developments/Updates
2.15 Norgine B.V
2.15.1 Norgine B.V Details
2.15.2 Norgine B.V Major Business
2.15.3 Norgine B.V IBS-C Drugs Product and Services
2.15.4 Norgine B.V IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Norgine B.V Recent Developments/Updates
2.16 Prometheus Laboratories Inc
2.16.1 Prometheus Laboratories Inc Details
2.16.2 Prometheus Laboratories Inc Major Business
2.16.3 Prometheus Laboratories Inc IBS-C Drugs Product and Services
2.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Prometheus Laboratories Inc Recent Developments/Updates
2.17 Actavis Nordic A/S
2.17.1 Actavis Nordic A/S Details
2.17.2 Actavis Nordic A/S Major Business
2.17.3 Actavis Nordic A/S IBS-C Drugs Product and Services
2.17.4 Actavis Nordic A/S IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Actavis Nordic A/S Recent Developments/Updates
2.18 Albireo Pharma Inc
2.18.1 Albireo Pharma Inc Details
2.18.2 Albireo Pharma Inc Major Business
2.18.3 Albireo Pharma Inc IBS-C Drugs Product and Services
2.18.4 Albireo Pharma Inc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Albireo Pharma Inc Recent Developments/Updates
2.19 Yuhan Corp
2.19.1 Yuhan Corp Details
2.19.2 Yuhan Corp Major Business
2.19.3 Yuhan Corp IBS-C Drugs Product and Services
2.19.4 Yuhan Corp IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Yuhan Corp Recent Developments/Updates
2.20 Astrazeneca Plc
2.20.1 Astrazeneca Plc Details
2.20.2 Astrazeneca Plc Major Business
2.20.3 Astrazeneca Plc IBS-C Drugs Product and Services
2.20.4 Astrazeneca Plc IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Astrazeneca Plc Recent Developments/Updates
2.21 The Menarini Group
2.21.1 The Menarini Group Details
2.21.2 The Menarini Group Major Business
2.21.3 The Menarini Group IBS-C Drugs Product and Services
2.21.4 The Menarini Group IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.21.5 The Menarini Group Recent Developments/Updates
2.22 Ono Pharmaceutical Co., Ltd
2.22.1 Ono Pharmaceutical Co., Ltd Details
2.22.2 Ono Pharmaceutical Co., Ltd Major Business
2.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Product and Services
2.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.22.5 Ono Pharmaceutical Co., Ltd Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: IBS-C DRUGS BY MANUFACTURER
3.1 Global IBS-C Drugs Sales Quantity by Manufacturer (2019-2024)
3.2 Global IBS-C Drugs Revenue by Manufacturer (2019-2024)
3.3 Global IBS-C Drugs Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of IBS-C Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 IBS-C Drugs Manufacturer Market Share in 2023
3.4.2 Top 6 IBS-C Drugs Manufacturer Market Share in 2023
3.5 IBS-C Drugs Market: Overall Company Footprint Analysis
3.5.1 IBS-C Drugs Market: Region Footprint
3.5.2 IBS-C Drugs Market: Company Product Type Footprint
3.5.3 IBS-C Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global IBS-C Drugs Market Size by Region
4.1.1 Global IBS-C Drugs Sales Quantity by Region (2019-2030)
4.1.2 Global IBS-C Drugs Consumption Value by Region (2019-2030)
4.1.3 Global IBS-C Drugs Average Price by Region (2019-2030)
4.2 North America IBS-C Drugs Consumption Value (2019-2030)
4.3 Europe IBS-C Drugs Consumption Value (2019-2030)
4.4 Asia-Pacific IBS-C Drugs Consumption Value (2019-2030)
4.5 South America IBS-C Drugs Consumption Value (2019-2030)
4.6 Middle East and Africa IBS-C Drugs Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global IBS-C Drugs Sales Quantity by Type (2019-2030)
5.2 Global IBS-C Drugs Consumption Value by Type (2019-2030)
5.3 Global IBS-C Drugs Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global IBS-C Drugs Sales Quantity by Application (2019-2030)
6.2 Global IBS-C Drugs Consumption Value by Application (2019-2030)
6.3 Global IBS-C Drugs Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America IBS-C Drugs Sales Quantity by Type (2019-2030)
7.2 North America IBS-C Drugs Sales Quantity by Application (2019-2030)
7.3 North America IBS-C Drugs Market Size by Country
7.3.1 North America IBS-C Drugs Sales Quantity by Country (2019-2030)
7.3.2 North America IBS-C Drugs Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe IBS-C Drugs Sales Quantity by Type (2019-2030)
8.2 Europe IBS-C Drugs Sales Quantity by Application (2019-2030)
8.3 Europe IBS-C Drugs Market Size by Country
8.3.1 Europe IBS-C Drugs Sales Quantity by Country (2019-2030)
8.3.2 Europe IBS-C Drugs Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific IBS-C Drugs Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific IBS-C Drugs Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific IBS-C Drugs Market Size by Region
9.3.1 Asia-Pacific IBS-C Drugs Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific IBS-C Drugs Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America IBS-C Drugs Sales Quantity by Type (2019-2030)
10.2 South America IBS-C Drugs Sales Quantity by Application (2019-2030)
10.3 South America IBS-C Drugs Market Size by Country
10.3.1 South America IBS-C Drugs Sales Quantity by Country (2019-2030)
10.3.2 South America IBS-C Drugs Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa IBS-C Drugs Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa IBS-C Drugs Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa IBS-C Drugs Market Size by Country
11.3.1 Middle East & Africa IBS-C Drugs Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa IBS-C Drugs Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 IBS-C Drugs Market Drivers
12.2 IBS-C Drugs Market Restraints
12.3 IBS-C Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of IBS-C Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of IBS-C Drugs
13.3 IBS-C Drugs Production Process
13.4 IBS-C Drugs Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 IBS-C Drugs Typical Distributors
14.3 IBS-C Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global IBS-C Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IBS-C Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Catalent Pharmaceuticals Solutions Basic Information, Manufacturing Base and Competitors
Table 4. Catalent Pharmaceuticals Solutions Major Business
Table 5. Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Services
Table 6. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Catalent Pharmaceuticals Solutions Recent Developments/Updates
Table 8. Nestle Basic Information, Manufacturing Base and Competitors
Table 9. Nestle Major Business
Table 10. Nestle IBS-C Drugs Product and Services
Table 11. Nestle IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Nestle Recent Developments/Updates
Table 13. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Laboratories Major Business
Table 15. Abbott Laboratories IBS-C Drugs Product and Services
Table 16. Abbott Laboratories IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Laboratories Recent Developments/Updates
Table 18. Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Synergy Pharmaceuticals Major Business
Table 20. Synergy Pharmaceuticals IBS-C Drugs Product and Services
Table 21. Synergy Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Synergy Pharmaceuticals Recent Developments/Updates
Table 23. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Sucampo Pharmaceuticals Major Business
Table 25. Sucampo Pharmaceuticals IBS-C Drugs Product and Services
Table 26. Sucampo Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sucampo Pharmaceuticals Recent Developments/Updates
Table 28. Novartis Pharma Ag Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Pharma Ag Major Business
Table 30. Novartis Pharma Ag IBS-C Drugs Product and Services
Table 31. Novartis Pharma Ag IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Novartis Pharma Ag Recent Developments/Updates
Table 33. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharmaceuticals Major Business
Table 35. Astellas Pharmaceuticals IBS-C Drugs Product and Services
Table 36. Astellas Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Astellas Pharmaceuticals Recent Developments/Updates
Table 38. Ardelyx, Inc Basic Information, Manufacturing Base and Competitors
Table 39. Ardelyx, Inc Major Business
Table 40. Ardelyx, Inc IBS-C Drugs Product and Services
Table 41. Ardelyx, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Ardelyx, Inc Recent Developments/Updates
Table 43. Synthetic Biologics, Inc Basic Information, Manufacturing Base and Competitors
Table 44. Synthetic Biologics, Inc Major Business
Table 45. Synthetic Biologics, Inc IBS-C Drugs Product and Services
Table 46. Synthetic Biologics, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Synthetic Biologics, Inc Recent Developments/Updates
Table 48. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 49. Teva Pharmaceutical Industries Major Business
Table 50. Teva Pharmaceutical Industries IBS-C Drugs Product and Services
Table 51. Teva Pharmaceutical Industries IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Teva Pharmaceutical Industries Recent Developments/Updates
Table 53. Bama-Geve, SLU Basic Information, Manufacturing Base and Competitors
Table 54. Bama-Geve, SLU Major Business
Table 55. Bama-Geve, SLU IBS-C Drugs Product and Services
Table 56. Bama-Geve, SLU IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Bama-Geve, SLU Recent Developments/Updates
Table 58. Ferring BV Basic Information, Manufacturing Base and Competitors
Table 59. Ferring BV Major Business
Table 60. Ferring BV IBS-C Drugs Product and Services
Table 61. Ferring BV IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Ferring BV Recent Developments/Updates
Table 63. Ironwood Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 64. Ironwood Pharmaceuticals, Inc Major Business
Table 65. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product and Services
Table 66. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Ironwood Pharmaceuticals, Inc Recent Developments/Updates
Table 68. Salix Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Salix Pharmaceuticals Ltd Major Business
Table 70. Salix Pharmaceuticals Ltd IBS-C Drugs Product and Services
Table 71. Salix Pharmaceuticals Ltd IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Salix Pharmaceuticals Ltd Recent Developments/Updates
Table 73. Norgine B.V Basic Information, Manufacturing Base and Competitors
Table 74. Norgine B.V Major Business
Table 75. Norgine B.V IBS-C Drugs Product and Services
Table 76. Norgine B.V IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Norgine B.V Recent Developments/Updates
Table 78. Prometheus Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 79. Prometheus Laboratories Inc Major Business
Table 80. Prometheus Laboratories Inc IBS-C Drugs Product and Services
Table 81. Prometheus Laboratories Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Prometheus Laboratories Inc Recent Developments/Updates
Table 83. Actavis Nordic A/S Basic Information, Manufacturing Base and Competitors
Table 84. Actavis Nordic A/S Major Business
Table 85. Actavis Nordic A/S IBS-C Drugs Product and Services
Table 86. Actavis Nordic A/S IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Actavis Nordic A/S Recent Developments/Updates
Table 88. Albireo Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 89. Albireo Pharma Inc Major Business
Table 90. Albireo Pharma Inc IBS-C Drugs Product and Services
Table 91. Albireo Pharma Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Albireo Pharma Inc Recent Developments/Updates
Table 93. Yuhan Corp Basic Information, Manufacturing Base and Competitors
Table 94. Yuhan Corp Major Business
Table 95. Yuhan Corp IBS-C Drugs Product and Services
Table 96. Yuhan Corp IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Yuhan Corp Recent Developments/Updates
Table 98. Astrazeneca Plc Basic Information, Manufacturing Base and Competitors
Table 99. Astrazeneca Plc Major Business
Table 100. Astrazeneca Plc IBS-C Drugs Product and Services
Table 101. Astrazeneca Plc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Astrazeneca Plc Recent Developments/Updates
Table 103. The Menarini Group Basic Information, Manufacturing Base and Competitors
Table 104. The Menarini Group Major Business
Table 105. The Menarini Group IBS-C Drugs Product and Services
Table 106. The Menarini Group IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. The Menarini Group Recent Developments/Updates
Table 108. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 109. Ono Pharmaceutical Co., Ltd Major Business
Table 110. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product and Services
Table 111. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 113. Global IBS-C Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 114. Global IBS-C Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global IBS-C Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 116. Market Position of Manufacturers in IBS-C Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and IBS-C Drugs Production Site of Key Manufacturer
Table 118. IBS-C Drugs Market: Company Product Type Footprint
Table 119. IBS-C Drugs Market: Company Product Application Footprint
Table 120. IBS-C Drugs New Market Entrants and Barriers to Market Entry
Table 121. IBS-C Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 123. Global IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 124. Global IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global IBS-C Drugs Average Price by Region (2019-2024) & (USD/Pcs)
Table 127. Global IBS-C Drugs Average Price by Region (2025-2030) & (USD/Pcs)
Table 128. Global IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 129. Global IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 130. Global IBS-C Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global IBS-C Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global IBS-C Drugs Average Price by Type (2019-2024) & (USD/Pcs)
Table 133. Global IBS-C Drugs Average Price by Type (2025-2030) & (USD/Pcs)
Table 134. Global IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 135. Global IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 136. Global IBS-C Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global IBS-C Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global IBS-C Drugs Average Price by Application (2019-2024) & (USD/Pcs)
Table 139. Global IBS-C Drugs Average Price by Application (2025-2030) & (USD/Pcs)
Table 140. North America IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 141. North America IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 142. North America IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 143. North America IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 144. North America IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 145. North America IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 146. North America IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 149. Europe IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 150. Europe IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 151. Europe IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 152. Europe IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 153. Europe IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 154. Europe IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 157. Asia-Pacific IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 158. Asia-Pacific IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 159. Asia-Pacific IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 160. Asia-Pacific IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 161. Asia-Pacific IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 162. Asia-Pacific IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 165. South America IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 166. South America IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 167. South America IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 168. South America IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 169. South America IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 170. South America IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 173. Middle East & Africa IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 174. Middle East & Africa IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 175. Middle East & Africa IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 176. Middle East & Africa IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 177. Middle East & Africa IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 178. Middle East & Africa IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 180. IBS-C Drugs Raw Material
Table 181. Key Manufacturers of IBS-C Drugs Raw Materials
Table 182. IBS-C Drugs Typical Distributors
Table 183. IBS-C Drugs Typical Customers
Table 1. Global IBS-C Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global IBS-C Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Catalent Pharmaceuticals Solutions Basic Information, Manufacturing Base and Competitors
Table 4. Catalent Pharmaceuticals Solutions Major Business
Table 5. Catalent Pharmaceuticals Solutions IBS-C Drugs Product and Services
Table 6. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Catalent Pharmaceuticals Solutions Recent Developments/Updates
Table 8. Nestle Basic Information, Manufacturing Base and Competitors
Table 9. Nestle Major Business
Table 10. Nestle IBS-C Drugs Product and Services
Table 11. Nestle IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Nestle Recent Developments/Updates
Table 13. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 14. Abbott Laboratories Major Business
Table 15. Abbott Laboratories IBS-C Drugs Product and Services
Table 16. Abbott Laboratories IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Abbott Laboratories Recent Developments/Updates
Table 18. Synergy Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Synergy Pharmaceuticals Major Business
Table 20. Synergy Pharmaceuticals IBS-C Drugs Product and Services
Table 21. Synergy Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Synergy Pharmaceuticals Recent Developments/Updates
Table 23. Sucampo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Sucampo Pharmaceuticals Major Business
Table 25. Sucampo Pharmaceuticals IBS-C Drugs Product and Services
Table 26. Sucampo Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sucampo Pharmaceuticals Recent Developments/Updates
Table 28. Novartis Pharma Ag Basic Information, Manufacturing Base and Competitors
Table 29. Novartis Pharma Ag Major Business
Table 30. Novartis Pharma Ag IBS-C Drugs Product and Services
Table 31. Novartis Pharma Ag IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Novartis Pharma Ag Recent Developments/Updates
Table 33. Astellas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 34. Astellas Pharmaceuticals Major Business
Table 35. Astellas Pharmaceuticals IBS-C Drugs Product and Services
Table 36. Astellas Pharmaceuticals IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Astellas Pharmaceuticals Recent Developments/Updates
Table 38. Ardelyx, Inc Basic Information, Manufacturing Base and Competitors
Table 39. Ardelyx, Inc Major Business
Table 40. Ardelyx, Inc IBS-C Drugs Product and Services
Table 41. Ardelyx, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Ardelyx, Inc Recent Developments/Updates
Table 43. Synthetic Biologics, Inc Basic Information, Manufacturing Base and Competitors
Table 44. Synthetic Biologics, Inc Major Business
Table 45. Synthetic Biologics, Inc IBS-C Drugs Product and Services
Table 46. Synthetic Biologics, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Synthetic Biologics, Inc Recent Developments/Updates
Table 48. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 49. Teva Pharmaceutical Industries Major Business
Table 50. Teva Pharmaceutical Industries IBS-C Drugs Product and Services
Table 51. Teva Pharmaceutical Industries IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Teva Pharmaceutical Industries Recent Developments/Updates
Table 53. Bama-Geve, SLU Basic Information, Manufacturing Base and Competitors
Table 54. Bama-Geve, SLU Major Business
Table 55. Bama-Geve, SLU IBS-C Drugs Product and Services
Table 56. Bama-Geve, SLU IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Bama-Geve, SLU Recent Developments/Updates
Table 58. Ferring BV Basic Information, Manufacturing Base and Competitors
Table 59. Ferring BV Major Business
Table 60. Ferring BV IBS-C Drugs Product and Services
Table 61. Ferring BV IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Ferring BV Recent Developments/Updates
Table 63. Ironwood Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 64. Ironwood Pharmaceuticals, Inc Major Business
Table 65. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product and Services
Table 66. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Ironwood Pharmaceuticals, Inc Recent Developments/Updates
Table 68. Salix Pharmaceuticals Ltd Basic Information, Manufacturing Base and Competitors
Table 69. Salix Pharmaceuticals Ltd Major Business
Table 70. Salix Pharmaceuticals Ltd IBS-C Drugs Product and Services
Table 71. Salix Pharmaceuticals Ltd IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Salix Pharmaceuticals Ltd Recent Developments/Updates
Table 73. Norgine B.V Basic Information, Manufacturing Base and Competitors
Table 74. Norgine B.V Major Business
Table 75. Norgine B.V IBS-C Drugs Product and Services
Table 76. Norgine B.V IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Norgine B.V Recent Developments/Updates
Table 78. Prometheus Laboratories Inc Basic Information, Manufacturing Base and Competitors
Table 79. Prometheus Laboratories Inc Major Business
Table 80. Prometheus Laboratories Inc IBS-C Drugs Product and Services
Table 81. Prometheus Laboratories Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Prometheus Laboratories Inc Recent Developments/Updates
Table 83. Actavis Nordic A/S Basic Information, Manufacturing Base and Competitors
Table 84. Actavis Nordic A/S Major Business
Table 85. Actavis Nordic A/S IBS-C Drugs Product and Services
Table 86. Actavis Nordic A/S IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Actavis Nordic A/S Recent Developments/Updates
Table 88. Albireo Pharma Inc Basic Information, Manufacturing Base and Competitors
Table 89. Albireo Pharma Inc Major Business
Table 90. Albireo Pharma Inc IBS-C Drugs Product and Services
Table 91. Albireo Pharma Inc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Albireo Pharma Inc Recent Developments/Updates
Table 93. Yuhan Corp Basic Information, Manufacturing Base and Competitors
Table 94. Yuhan Corp Major Business
Table 95. Yuhan Corp IBS-C Drugs Product and Services
Table 96. Yuhan Corp IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Yuhan Corp Recent Developments/Updates
Table 98. Astrazeneca Plc Basic Information, Manufacturing Base and Competitors
Table 99. Astrazeneca Plc Major Business
Table 100. Astrazeneca Plc IBS-C Drugs Product and Services
Table 101. Astrazeneca Plc IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Astrazeneca Plc Recent Developments/Updates
Table 103. The Menarini Group Basic Information, Manufacturing Base and Competitors
Table 104. The Menarini Group Major Business
Table 105. The Menarini Group IBS-C Drugs Product and Services
Table 106. The Menarini Group IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. The Menarini Group Recent Developments/Updates
Table 108. Ono Pharmaceutical Co., Ltd Basic Information, Manufacturing Base and Competitors
Table 109. Ono Pharmaceutical Co., Ltd Major Business
Table 110. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product and Services
Table 111. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales Quantity (K Pcs), Average Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 112. Ono Pharmaceutical Co., Ltd Recent Developments/Updates
Table 113. Global IBS-C Drugs Sales Quantity by Manufacturer (2019-2024) & (K Pcs)
Table 114. Global IBS-C Drugs Revenue by Manufacturer (2019-2024) & (USD Million)
Table 115. Global IBS-C Drugs Average Price by Manufacturer (2019-2024) & (USD/Pcs)
Table 116. Market Position of Manufacturers in IBS-C Drugs, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 117. Head Office and IBS-C Drugs Production Site of Key Manufacturer
Table 118. IBS-C Drugs Market: Company Product Type Footprint
Table 119. IBS-C Drugs Market: Company Product Application Footprint
Table 120. IBS-C Drugs New Market Entrants and Barriers to Market Entry
Table 121. IBS-C Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 122. Global IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 123. Global IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 124. Global IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 125. Global IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 126. Global IBS-C Drugs Average Price by Region (2019-2024) & (USD/Pcs)
Table 127. Global IBS-C Drugs Average Price by Region (2025-2030) & (USD/Pcs)
Table 128. Global IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 129. Global IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 130. Global IBS-C Drugs Consumption Value by Type (2019-2024) & (USD Million)
Table 131. Global IBS-C Drugs Consumption Value by Type (2025-2030) & (USD Million)
Table 132. Global IBS-C Drugs Average Price by Type (2019-2024) & (USD/Pcs)
Table 133. Global IBS-C Drugs Average Price by Type (2025-2030) & (USD/Pcs)
Table 134. Global IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 135. Global IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 136. Global IBS-C Drugs Consumption Value by Application (2019-2024) & (USD Million)
Table 137. Global IBS-C Drugs Consumption Value by Application (2025-2030) & (USD Million)
Table 138. Global IBS-C Drugs Average Price by Application (2019-2024) & (USD/Pcs)
Table 139. Global IBS-C Drugs Average Price by Application (2025-2030) & (USD/Pcs)
Table 140. North America IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 141. North America IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 142. North America IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 143. North America IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 144. North America IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 145. North America IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 146. North America IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 147. North America IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 148. Europe IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 149. Europe IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 150. Europe IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 151. Europe IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 152. Europe IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 153. Europe IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 154. Europe IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 155. Europe IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 156. Asia-Pacific IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 157. Asia-Pacific IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 158. Asia-Pacific IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 159. Asia-Pacific IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 160. Asia-Pacific IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 161. Asia-Pacific IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 162. Asia-Pacific IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 163. Asia-Pacific IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 164. South America IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 165. South America IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 166. South America IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 167. South America IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 168. South America IBS-C Drugs Sales Quantity by Country (2019-2024) & (K Pcs)
Table 169. South America IBS-C Drugs Sales Quantity by Country (2025-2030) & (K Pcs)
Table 170. South America IBS-C Drugs Consumption Value by Country (2019-2024) & (USD Million)
Table 171. South America IBS-C Drugs Consumption Value by Country (2025-2030) & (USD Million)
Table 172. Middle East & Africa IBS-C Drugs Sales Quantity by Type (2019-2024) & (K Pcs)
Table 173. Middle East & Africa IBS-C Drugs Sales Quantity by Type (2025-2030) & (K Pcs)
Table 174. Middle East & Africa IBS-C Drugs Sales Quantity by Application (2019-2024) & (K Pcs)
Table 175. Middle East & Africa IBS-C Drugs Sales Quantity by Application (2025-2030) & (K Pcs)
Table 176. Middle East & Africa IBS-C Drugs Sales Quantity by Region (2019-2024) & (K Pcs)
Table 177. Middle East & Africa IBS-C Drugs Sales Quantity by Region (2025-2030) & (K Pcs)
Table 178. Middle East & Africa IBS-C Drugs Consumption Value by Region (2019-2024) & (USD Million)
Table 179. Middle East & Africa IBS-C Drugs Consumption Value by Region (2025-2030) & (USD Million)
Table 180. IBS-C Drugs Raw Material
Table 181. Key Manufacturers of IBS-C Drugs Raw Materials
Table 182. IBS-C Drugs Typical Distributors
Table 183. IBS-C Drugs Typical Customers
LIST OF FIGURES
Figure 1. IBS-C Drugs Picture
Figure 2. Global IBS-C Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IBS-C Drugs Consumption Value Market Share by Type in 2023
Figure 4. Linaclotide Examples
Figure 5. Lubiprostone Examples
Figure 6. Osmotic Laxatives Examples
Figure 7. Stimulant Laxatives Examples
Figure 8. Others Examples
Figure 9. Global IBS-C Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global IBS-C Drugs Consumption Value Market Share by Application in 2023
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global IBS-C Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global IBS-C Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global IBS-C Drugs Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global IBS-C Drugs Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global IBS-C Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global IBS-C Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of IBS-C Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 IBS-C Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 IBS-C Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global IBS-C Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global IBS-C Drugs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global IBS-C Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global IBS-C Drugs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. IBS-C Drugs Market Drivers
Figure 77. IBS-C Drugs Market Restraints
Figure 78. IBS-C Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of IBS-C Drugs in 2023
Figure 81. Manufacturing Process Analysis of IBS-C Drugs
Figure 82. IBS-C Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. IBS-C Drugs Picture
Figure 2. Global IBS-C Drugs Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global IBS-C Drugs Consumption Value Market Share by Type in 2023
Figure 4. Linaclotide Examples
Figure 5. Lubiprostone Examples
Figure 6. Osmotic Laxatives Examples
Figure 7. Stimulant Laxatives Examples
Figure 8. Others Examples
Figure 9. Global IBS-C Drugs Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 10. Global IBS-C Drugs Consumption Value Market Share by Application in 2023
Figure 11. Hospital Pharmacies Examples
Figure 12. Retail Pharmacies Examples
Figure 13. Online Pharmacies Examples
Figure 14. Global IBS-C Drugs Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global IBS-C Drugs Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global IBS-C Drugs Sales Quantity (2019-2030) & (K Pcs)
Figure 17. Global IBS-C Drugs Average Price (2019-2030) & (USD/Pcs)
Figure 18. Global IBS-C Drugs Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global IBS-C Drugs Consumption Value Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of IBS-C Drugs by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 21. Top 3 IBS-C Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 22. Top 6 IBS-C Drugs Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Global IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 25. North America IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 28. South America IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa IBS-C Drugs Consumption Value (2019-2030) & (USD Million)
Figure 30. Global IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global IBS-C Drugs Consumption Value Market Share by Type (2019-2030)
Figure 32. Global IBS-C Drugs Average Price by Type (2019-2030) & (USD/Pcs)
Figure 33. Global IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global IBS-C Drugs Consumption Value Market Share by Application (2019-2030)
Figure 35. Global IBS-C Drugs Average Price by Application (2019-2030) & (USD/Pcs)
Figure 36. North America IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 40. United States IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 41. Canada IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Mexico IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Europe IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. France IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. United Kingdom IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. Russia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Italy IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 56. China IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Japan IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Korea IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. India IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. Southeast Asia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Australia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. South America IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America IBS-C Drugs Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America IBS-C Drugs Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 67. Argentina IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa IBS-C Drugs Sales Quantity Market Share by Region (2019-2030)
Figure 71. Middle East & Africa IBS-C Drugs Consumption Value Market Share by Region (2019-2030)
Figure 72. Turkey IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Egypt IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Saudi Arabia IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. South Africa IBS-C Drugs Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. IBS-C Drugs Market Drivers
Figure 77. IBS-C Drugs Market Restraints
Figure 78. IBS-C Drugs Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of IBS-C Drugs in 2023
Figure 81. Manufacturing Process Analysis of IBS-C Drugs
Figure 82. IBS-C Drugs Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
